Delivery Order SPE2DB22D1202-SPE2DB24FUTD0
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.99 firm fixed-price contract is for the supply of Trileptal 300 mg/5 ml suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a firm-fixed price delivery order with a ceiling value of $1,099.02 and a period of performance through March 22, 2023. AmerisourceBergen is the prime contractor, and there is no indication of any set-aside requirements for this award. This contract is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.43, is for the delivery of Trileptal 300 mg/5 ml suspension, a pharmaceutical product, with a completion date of January 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.59 Firm Fixed Price Delivery Order, with a completion date of March 1, 2023, is for the supply of 4560094860 - TRILEPTAL 300 MG/5 ML SUSP 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Trileptal 300 mg/5 ml suspension. The $2,368.56 firm fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a $1,890.63 order for the pharmaceutical product Trileptal 300 mg/5 ml suspension. The contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for 250ml bottles of the drug Trileptal at a potential value of $2,380.08 with a completion date of February 26, 2024. This award is made under Amerisourcebergen Drug Corp's prime contract with DLA, an indefinite delivery contract (IDC) with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,869.87 firm fixed price Delivery Order is for the supply of 4558630619 - TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The contract has a completion date of September 29, 2022 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,052.32 contract is for the procurement of 4,562,235,883 units of the medication Trileptal 300 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The $1,486.26 firm fixed-price delivery order was awarded on January 5, 2022, with a completion date of January 6, 2022. The contract has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTD0Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $4,832.27 order is for the supply of Trileptal 300mg/5ml oral suspension, a prescription medication. The delivery order was issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 3/11/24 |